Physiomics PLC | Cash Flow

Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
548.30
465.30
414.80
431.60
530.60
183.30
Depreciation, Depletion & Amortization
8.50
7.90
6.60
6.40
4.90
3.20
Other Funds
48.70
38.00
66.50
92.50
112.50
9
Funds from Operations
491.10
419.40
341.60
332.60
413.20
171.10
Changes in Working Capital
28.90
68.90
50.70
14.10
23.90
1.40
Net Operating Cash Flow
519.90
350.50
392.30
346.70
437.10
169.80
Capital Expenditures
1.90
2.60
0.60
1.80
6.80
Net Investing Cash Flow
1.90
2.60
0.60
1.10
6.80
Net Financing Cash Flow
10.00
306.30
527.40
220.00
514.80
Net Change in Cash
511.80
46.80
134.40
127.80
70.80
Free Cash Flow
521.80
353.10
393.00
348.60
443.90
Other Sources
-
-
-
0.70
-
Change in Capital Stock
10.00
306.30
527.40
220.00
514.80

About Physiomics

View Profile
Address
The Magdalen Centre
Oxford Oxfordshire OX4 4GA
United Kingdom
Employees -
Website http://www.physiomics-plc.com
Updated 07/08/2019
Physiomics Plc engages in the provision of outsourced systems and computational biology services to pharmaceutical companies. Its services include target validation, mechanism of action studies, lead selection, clinical PK or PD, EasyAP or cardiac toxicity service, virtual tumour preclinical, and virtual tumour clinical. The company was founded by David A.